Verve Therapeutics Inc Revenue per Employee (VERV), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Verve Therapeutics Inc   (NASDAQ: VERV)
 

Verve Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 479.03% in the first quarter 2025, year on year to cumulative value of $60 million, Verve Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 2,838,714, this marks a new company high.
Within the Healthcare sector Employees of 33 other companies have achieved higher revenue per employee. While Verve Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 260 to 352. Verve Therapeutics Inc has 21 employees.


What is Sales per Employee Ratio?







VERV Revenue per Employee (Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
Y / Y Revenue Change 479.03 % 154.28 % 120.24 % 219.73 % 305.63 %
Sales per Employee (TTM) $ 2,838,714 1,539,619 1,161,714 983,238 764,238
VERV's Total Ranking # 352 # 260 # 553 # 0 # 0
Seq. Revenue Change 152.11 % 90.53 % 2.59 % 17.51 % 10.71 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 21
Healthcare Sector # 34
Overall Market # 352

Revenue per Employee Statistics
High Average Low
$ 2,838,714 $ 1,058,690 $ 258,952
(Mar 31 2025)   (Jun 30 2023)



Financial Statements
Verve Therapeutics Inc 's Revenue MRQ $ 33 Millions Visit VERV's Income Statement
Verve Therapeutics Inc 's Revenues TTM $ 60 Millions Visit VERV's aggregate revenue growth
What are VERV's Sales? Visit VERV's Sales by Segment




Other Ratios
Verve Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VERV's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VERV's Competitors
Revenue per Employee for VERV's Suppliers
Revenue per Employee for VERV's Customers

You may also want to know
VERV's Sales Growth Rates VERV's Pe Price to earnings ratio VERV's Receivables Turnover Ratio VERV's Stock Quote
VERV's Net Income Growth Rates VERV's Ps Price to Sales ratio VERV's Sales per Employee VERV's Asset Turnover Ratio
VERV's Net Margin VERV's Pb Price to Book ratio VERV's Financial Strength Ratios VERV's Dividend Payout Ratio
Date modified: 2026-08-29T17:44:55+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2025Number of Employees Mar 31 2025
Anika Therapeutics Inc   4,961,714.29 $ 104.196  Million 21 
P3 Health Partners Inc   4,641,225.00 $ 1,485.192  Million 320 
Aytu Biopharma Inc  4,280,187.50 $ 68.483  Million 16 
Community Health Systems Inc   4,081,612.90 $ 12,653.000  Million 3,100 
Ligand Pharmaceuticals Incorporated  3,857,276.60 $ 181.292  Million 47 
Xeris Biopharma Holdings Inc   3,423,861.54 $ 222.551  Million 65 
Illumina Inc   3,388,281.25 $ 4,337.000  Million 1,280 
Ironwood Pharmaceuticals inc   3,176,760.00 $ 317.676  Million 100 
Keros Therapeutics Inc   3,066,602.56 $ 239.195  Million 78 
Xoma Royalty Corporation  3,064,928.57 $ 42.909  Million 14 
Catalyst Pharmaceuticals Inc   2,937,615.38 $ 534.646  Million 182 
Verve Therapeutics Inc   2,838,714.29 $ 59.613  Million 21 
Sarepta Therapeutics Inc   2,674,695.81 $ 2,233.371  Million 835 
Amgen Inc   2,625,076.92 $ 34,126.000  Million 13,000 
Springworks Therapeutics Inc   2,615,119.05 $ 219.670  Million 84 
Innoviva Inc   2,568,257.86 $ 408.353  Million 159 
Halozyme Therapeutics Inc   2,563,371.16 $ 1,084.306  Million 423 
Harmony Biosciences Holdings inc   2,537,634.81 $ 743.527  Million 293 
Siga Technologies Inc  2,455,720.61 $ 120.330  Million 49 
Assertio Holdings inc   2,245,301.89 $ 119.001  Million 53 
United Therapeutics Corporation  2,138,642.86 $ 2,994.100  Million 1,400 
Cytomx Therapeutics Inc   2,138,507.25 $ 147.557  Million 69 
Indivior Pharmaceuticals Inc   2,059,000.00 $ 2,059.000  Million 1,000 
Prothena Corporation Public Limited Company  2,058,731.34 $ 137.935  Million 67 
Exelixis Inc   2,004,291.19 $ 2,298.922  Million 1,147 
Prestige Consumer Healthcare Inc   1,995,549.12 $ 1,137.463  Million 570 
Aurinia Pharmaceuticals Inc   1,931,992.19 $ 247.295  Million 128 
Therapeuticsmd Inc   1,841,000.00 $ 1.841  Million
Ptc Therapeutics inc   1,788,857.72 $ 1,772.758  Million 991 
Spero Therapeutics Inc   1,783,360.00 $ 44.584  Million 25 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.